PRECINCT is the first comparative oncology clinical trials network. The PRECINCT is led by Dr. Nicola Mason and Dr. Qi Long at the School of Veterinary Medicine and the Department of Biostatistics at The University of Pennsylvania respectively. The PRECINCT provides members access to unparalleled expertise in design, coordination, and implementation of clinical trials and data management, biostatistical support, and clinical immunological monitoring and correlative studies. The Data Coordinating Center (DCC) within PRECINCT provides administrative support for the PRECINCT and serves to harmonize clinical and immunological data from each study site within the network to further our understanding of combination immunotherapies and correlative biomarkers of activity and efficacy in pets dogs with spontaneous tumors.
PRECINCT’s Steering Committee (SC) consist of one PI from each of the five Clinical Research Centers; one representative from the PRECINCT; the NCI Project Officer and one representative from the COP of the NCI. The SC works to guide and implement policies and procedures for single site investigations and collaborative projects.
